...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Need An Explanation
6
May 17, 2016 11:09AM
2
May 17, 2016 11:20AM
5
May 17, 2016 11:34AM
5
May 17, 2016 11:35AM
3
May 17, 2016 11:38AM
Some good points made here. One question I have, which I emailed Zenith about last night, is does this latest financing dilute Zenith Capital Corp. I suspect it does but one of the reasons for the reorg was supposedly to prevent dilution of ownership of RVX royalty preferred shares. Since this financing was done after the vote on the reorg but prior to the execution of the split it seems like a bit of a grey area. I will share my answer if I get one.
3
May 17, 2016 03:21PM
1
May 17, 2016 04:08PM
4
May 17, 2016 04:28PM
2
May 17, 2016 05:10PM
3
May 17, 2016 06:26PM
1
May 17, 2016 10:10PM
3
May 18, 2016 07:05AM
Share
New Message
Please login to post a reply